CHICAGO (June 21, 2023) — The National Rosacea Society (NRS) today announced that it is launching a Seal of Acceptance program to identify skin care and cosmetic products that may be suitable for people who suffer from rosacea. Companies interested in pursuing the Seal, to be displayed on accepted product packaging, may learn more and request an application online at www.rosacea.org/seal-of-acceptance/ or by contacting the Society at email@example.com.
“One of the most common requests the Society receives from rosacea patients is for information about which skin care and cosmetic products are appropriate to use,” said Andrew Huff, president and executive director of the NRS. “We are excited to offer this new way to provide guidance to rosacea sufferers by recognizing products that have been shown to be unlikely to cause a flare-up.”
Sensitive and easily irritated skin is a common issue for people with rosacea, a chronic disorder affecting an estimated 16 million Americans and 415 million people worldwide. In NRS surveys, 92% of rosacea sufferers reported burning, stinging or itching skin; 66% named certain skin care or cosmetic products as triggers for rosacea signs and symptoms; and 84% were “very interested” in more guidance on skin care.
The Seal of Acceptance program was developed under the guidance of Zoe Diana Draelos, MD, FAAD, a clinical and research dermatologist and president of Dermatology Consulting Services, PLLC, who is a well-known authority on skin care and serves on the NRS board of directors. To be considered for the Seal, skin care and cosmetic products must be free of ingredients that cause skin barrier dysfunction, vasomotor instability (flushing) or unwanted neurosensory stimulation, such as burning or itching. Applicants must provide a full list of ingredients as well as human repeat insult patch test (HRIPT) data on at least 30 people and safety-in-use test data on at least 30 rosacea patients.
Applications are anonymously reviewed by an independent panel of dermatologists. If approved, the Seal may be licensed for display on product packaging and marketing materials, and will be listed in a directory of accepted products to debut when the program launches to the public later in 2023.
Rosacea is a chronic disorder of the facial skin that is often characterized by flare-ups and remissions. According to the updated standard classification of rosacea, the presence of persistent facial erythema or, less commonly, phymatous changes where the facial skin thickens is considered diagnostic of the disorder. Additional major signs, which often appear with the diagnostic features, include papules and pustules, flushing, telangiectasia and certain ocular manifestations. The presence of two or more major features independent of the diagnostic signs is also considered diagnostic of rosacea, and secondary signs and symptoms include burning or stinging, swelling and dry appearance.
About the National Rosacea Society
The National Rosacea Society is the world's largest organization dedicated to improving the lives of the estimated 16 million Americans who suffer from this widespread but poorly understood disorder. The 501(c)(3) nonprofit's mission is to raise awareness of rosacea, provide public health information on the disorder and support medical research that may lead to improvements in its management, prevention and potential cure.
In addition to the NRS website at rosacea.org, the NRS may be followed on Facebook, Twitter, Instagram and Pinterest for up-to-date information and tips on rosacea. Further information may be obtained by writing the National Rosacea Society, 4619 N. Ravenswood Ave., Ste. 103, Chicago, Illinois 60640; via email at firstname.lastname@example.org; or by calling its toll-free number at 1-888-NO-BLUSH.